Recruiting
Study on the Health Economic Burden of Alzheimer's Disease in China
About this study
Alzheimer's disease (AD) presents a significant socio-economic challenge globally, with China experiencing a notable rise in its prevalence. This study addresses critical gaps in understanding AD's economic burden and quality of life (QoL) impacts on patients and caregivers in Mainland China.
- Condition
- Alzheimer Disease
- Tested
- There was no intervention as this was an observational study.
- Sponsor
- Xuanwu Hospital, Beijing
Who can join
- Age
- 40 to 100 years
- Sex
- All sexes
- Healthy volunteers
- Not accepted
Inclusion 11
- Minimum age: 40 years
- Maximum age: 100 years
- Study condition: Alzheimer Disease
- Diagnosed according to the National Institute on Aging-Alzheimer's 1.Association (NIA-AA) criteria for aMCI and AD.
- Clinical Dementia Rating (CDR) score greater than or equal to 0.5 3.Have good visual, auditory, and language functions, or can complete neuropsychological assessments after correction.
- Participants or their legal representatives sign informed consent. Exclusion criteria
- History of stroke with neurological focal signs and imaging findings consistent with cerebral small vessel disease (Modified Fazekas score ≥2).
- Presence of mental or neurological developmental delay.
- Presence of other known conditions that may cause cognitive impairment.
- Diagnosis of a disease that prevents completion of cognitive assessments.
- Refusal to sign informed consent at baseline.
Where
1 site, 1 recruiting
Xuanwu Hospital, Capital Medical University
Beijing, China
Potential match only. Final eligibility is determined by the study team.